Τίτλος:
Efficacy and safety of weekly carfilzomib (70 mg/m2), dexamethasone, and daratumumab (KdD70) is comparable to twice-weekly KdD56 while being a more convenient dosing option: a cross-study comparison of the CANDOR and EQUULEUS studies
Συγγραφείς:
Leleu, Xavier
Beksac, Meral
Chou, Takaaki
Dimopoulos, Meletios
Yoon, Sung-Soo
Prince, H Miles
Pour, Ludek
Shelekhova, Tatiana
Chari, Ajai
Khurana, Monica
others